Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harvard Apparatus Regenerative Technology (HRGN) EBITDA Margin (2013 - 2026)

Updated

Harvard Apparatus Regenerative Technology's EBITDA Margin came in at -408.45% for Q2 2026, up 169.46 percentage points from -577.92% a year earlier and up 301.72 percentage points from the prior quarter.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) EBITDA Margin (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Harvard Apparatus Regenerative Technology reported EBITDA Margin of -682.89%, up 306.95 percentage points year-over-year; for FY2025, it came in at -981.53%, up 811.95 percentage points from FY2024.

  • Going back by year, EBITDA Margin was -1793.49% in FY2024 (+6900.69 pp) and -8694.17% in FY2023.
  • The Q2 2026 figure represents the highest quarterly EBITDA Margin in data going back to Q4 2013.
  • Year-over-year, EBITDA Margin increased in six of the last eight quarters, with an average year-over-year change of +1450.92 percentage points.
  • The fastest year-over-year change in EBITDA Margin over five years came in Q2 2025 (a gain of 3843.51 percentage points), and the weakest in Q4 2025 (a drop of 246.59 percentage points).
  • Business Quant data shows HRGN's EBITDA Margin at -710.18% (Q1 2026), -774.89% (Q4 2025) and -1392.68% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 35.95%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 49.01%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.02%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 33.11%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 46.01%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -124.26%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 39.16%
10 Harvard Apparatus Regenerative Technology 38.50 Mn 35.01 Mn 23,000.00 -408.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -408.45%
Mar 31, 2026 -710.18%
Dec 31, 2025 -774.89%
Sep 30, 2025 -1,392.68%
Jun 30, 2025 -577.92%
Mar 31, 2025 -3,706.67%
Dec 31, 2024 -528.29%
Sep 30, 2024 -3,149.15%
Jun 30, 2024 -4,421.43%
Mar 31, 2024 -3,535.09%
Dec 31, 2023 -2,892.06%
Sep 30, 2023 -4,045.00%
Dec 31, 2016 -12,389.29%
Sep 30, 2016 -11,665.38%
Jun 30, 2016 -10,032.14%
Dec 31, 2015 -26,987.50%
Sep 30, 2015 -5,867.57%
Jun 30, 2015 -6,006.85%
Dec 31, 2014 -6,077.78%
Sep 30, 2014 -128,550.00%
API Access

Harvard Apparatus Regenerative Technology EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HRGN&period=max&api_key=YOUR_API_KEY